Addition of hepatologist to the article: Reccomendation for vaccination in patients with Crohn´s disease and ulcerative colitis on Immunosupressive and/or biological therapy (Čes a Slov Gastroent a Hepatol 2010; 64(1): 40–48)

Česká verzia

Authors: J. Šperl ¹ ; J. Špičák ¹; M. Lukáš ² ; Pracovní Skupina Pro Idiopatické Střevní Záněty Čgs
Authors place of work: Hepato-gastroenterologická klinika IKEM, Praha ¹; Klinické a výzkumné centrum pro střevní záněty ISCARE a 1. LF UK, Praha ²
Published in the journal: Gastroent Hepatol 2010; 64(2): 37-38
Category: Erratum

Zdroje

1. Beasley RP, Hwang LY, Lin CC et al. Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis 1982; 146(2): 198–204.

2. Coursaget P, Yvonnet B, Chotard J et al. Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). J Med Virol 1987; 22(1): 1–5.

3. Marusawa H, Uemoto S, Hijikata M et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 2000; 31(2): 488–495.

4. Rehermann B, Ferrari C, Pasquinelli C et al. The hepatitis B virus persists for decades after patients‘ recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996; 2(10): 1104–1108.

5. Yotsuyanagi H, Yasuda K, Iino S et al. Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology 1998; 27(5): 1377–1382.

6. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45(2): 507–539.

7. Cheng AL, Hsiung CA, Su IJ et al. Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma. Hepatology 2003; 37(6): 1320–1328.

8. Šperl J, Špičák J. Problematika virových hepatitid v průběhu léčby preparáty s anti-TNFa aktivitou. Biol Lecba 2009; 2(2): 69.

9. Tilg H, Vogelsang H, Ludwiczek O et al. A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis. Gut 2003; 52(12): 1728–1733.

10. Rahier J, Ben-Horin S, Chowers Y et al. Europen evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. Journal of Crohn´s and Colitis 2009; 3(2): 47–91.